marijuana stocks

Advanced Cannabis Solutions, Inc. (CANN)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Mar 31, 2014 Dec 31, 2013
Total Revenue 97   14   49   (22)
Cost of Revenue 66 (15) (12)
Gross Profit 31   29   49   (9)
Operating Expenses
Research Development
Selling General and Administrative 735 1,342 961 233
Non Recurring
Others 47 13 3
Total Operating Expenses
Operating Income or Loss (752) (1,325) (915) (242)
Income from Continuing Operations
Total Other Income/Expenses Net (2,962) (346) (953) (1)
Earnings Before Interest And Taxes (3,714) (1,671) (1,869) (243)
Interest Expense 41 76 50 1
Income Before Tax (3,755) (1,747) (1,919) (244)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (3,755) (1,747) (1,919) (244)
Non-recurring Events
Discontinued Operations 2 11
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (3,755) (1,747) (1,917) (233)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (3,755) (1,747) (1,917) (233)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Greenlane Holdings, Inc. (GNLN) And KushCo Holdings Inc. (KSHB) Announce Transformative Merger, Creating the Leading Ancillary Cannabis Company

Greenlane and KushCo Announce Transformative Merger, Creating the Leading Ancillary Cannabis Company…

Organigram Holdings Inc. (OGI) Increases Investment in Phylos After Successful Milestone Achievement

Organigram Increases Investment in Phylos After Successful Milestone Achievement Organigram Holdings Inc.…

$FWDG CB Scientific Introduces Next-Gen Cannabis THC & CBD Detection Kits

FutureWorld (FWDG) CB Scientific Introduces Next-Gen Cannabis THC & CBD Detection Kits…

Cara Therapeutics, Inc. (CARA) to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results…